News

MannKind Corporation to Present at Investor Conferences

MannKind Corporation to Present at Investor Conferences

MannKind Corporation to Present at Investor Conferences

MannKind Corporation (Nasdaq: MNKD) is dedicated to developing and commercializing innovative inhaled therapeutic products and devices for patients suffering from endocrine and orphan lung diseases. The company's Chief Executive Officer, Michael Castagna, PharmD, along with Chief Financial Officer, Chris Prentiss, will share important updates at several upcoming investor conferences.

Upcoming Presentation Events

In the coming weeks, executives from MannKind Corporation will engage in fireside chats at prominent investor conferences. These events present a valuable opportunity for interested individuals to gain insights into the company's strategic direction.

2024 Wells Fargo Healthcare Conference

The first event on the agenda is the 2024 Wells Fargo Healthcare Conference, which will take place in Boston. Scheduled for Wednesday, September 4, at 11:00 a.m. Eastern Time, this session will provide attendees with an overview of the latest developments at MannKind.

Morgan Stanley Annual Global Healthcare Conference

Next, MannKind will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference in New York on Friday, September 6, at 7:00 a.m. Eastern Time. This conference will offer further insights into the company's initiatives.

H.C. Wainwright Annual Global Investment Conference

Finally, MannKind executives will attend the H.C. Wainwright 26th Annual Global Investment Conference in New York on Tuesday, September 10, at 9:30 a.m. Eastern Time. This event will serve as another platform to discuss the company's innovations and future plans.

Audio Webcasts and Access

For those who cannot attend these sessions in person, MannKind Corporation will provide links for live audio webcasts on their official website. Additionally, an archived version will be available for about 30 days after each conference, allowing investors and stakeholders to review the discussions at their convenience.

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) is committed to the development and commercialization of innovative inhaled therapeutic products. Their mission focuses on addressing serious unmet medical needs for individuals living with endocrine and orphan lung diseases. Current advancements include formulations and devices targeting conditions such as diabetes, nontuberculous mycobacterial lung disease, pulmonary fibrosis, and pulmonary hypertension.

By utilizing cutting-edge dry-powder formulations and inhalation devices, MannKind enables rapid and convenient medication delivery, specifically tailored to achieve either local or systemic effects based on the required indication. This innovative approach underscores their dedication to enhancing the quality of life for patients.

Innovative Technologies and Commitments

MannKind stands at the forefront of the medical technology sector, led by a passionate team known as Mannitarians, who are fully engaged in their mission. The company combines its formulation capabilities with device engineering expertise to help alleviate the challenges posed by complex diseases.

MannKind Corporation aims to empower individuals to take greater control over their health, ultimately allowing them the freedom to participate fully in life. As the industry continues to evolve, the company plans to maintain its focus on advancing therapeutic innovations that truly make a difference.

Stay Connected for Updates

For more information regarding MannKind Corporation's initiatives, products, and investor updates, please visit their official website. Stakeholders are also encouraged to follow the company on various social media platforms to stay informed about the latest developments.

Frequently Asked Questions

What is MannKind Corporation known for?

MannKind Corporation is recognized for its innovative inhaled therapeutic products and devices designed to address serious unmet medical needs.

Who will present at the upcoming conferences?

The conferences will feature presentations by Michael Castagna, PharmD, the CEO, and Chris Prentiss, the CFO.

Where can I access the live audio webcasts?

Live audio webcasts will be accessible through MannKind Corporation’s official website during the conferences.

What are the key diseases MannKind is targeting?

MannKind is focused on diseases such as diabetes, nontuberculous mycobacterial lung disease, pulmonary fibrosis, and pulmonary hypertension.

How can investors learn more about MannKind Corporation?

Investors can find more information by visiting the company's website and following them on social media for updates.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Claigan Webinar Tackles Prop 65 Warnings for 2028

Updated Category News Views 5

Buckle up, folks. Here comes a wake-up call for businesses playing loose with their compliance homework on California's Prop 65, thanks to Claigan's latest announcement. They're hosting a webinar on October 7, 2026, gearing up everyone who'll listen for the changes hitting the books in 2028. We’re zooming past the days of generic warnings; pretty soon, it'll be all...

Continue Reading
Kansas Marijuana DUI Laws: What Drivers Must Know

Updated Category News Views 4

Navigating the Legal Maze of Marijuana DUIs Marijuana DUI, ever heard of it? Many folks in Kansas might just find themselves scratching their heads. While booze clearly shouts 'DUI' when you hit the road sauced, the green stuff doesn’t dodge that same bullet. You better believe it, Kansas doesn’t mess around when it comes to drugs behind the wheel, and marijuana is...

Continue Reading
Schneider Electric Pushes Water Management Tech at WEFTEC

Updated Category News Views 13

Looks like Schneider Electric is diving headfirst into the choppy waters of utility management with its latest tech showcase at WEFTEC 2026. And trust me, the timing couldn't be more spot-on. With North America's water and wastewater systems groaning under the weight of aging infrastructure and cybersecurity threats, it’s about time someone brought something fresh to...

Continue Reading
Craig Hospital Expands: A Milestone for Rehab Care

Updated Category News Views 6

A Bold Step Forward in Neurorehabilitation Over a September sky in Englewood, Colorado, a ceremonial beam rose, marking a major milestone for Craig Hospital. It's not just steel and concrete; it's hope and progress for many who've found themselves at the mercy of neurological injuries. Celebrating the 'topping out' of their expanded campus, Craig's latest step forward...

Continue Reading
New Leadership at Newmark: Tech Focus Amplified

Updated Category News Views 4

A Strategic Leap in Tech Leadership Newmark Group, Inc. (NASDAQ: NMRK) has handed the digital reins to Mike Whitaker, bringing him on board as Group Chief Information Officer. If you're in the loop with commercial real estate, this shakeup shouldn't come as a surprise. Newmark's been pretty gung-ho about tightening their tech playbook, and Whitaker's appointment is just...

Continue Reading
Books-A-Million's Impactful 2026 Coffee for Troops Campaign

Updated Category News Views 3

A Modest Cup, A Massive Impact Ever wonder how something as simple as a bag of coffee could bridge the gap between a service member far from home and their loved ones? Well, Books-A-Million has got that figured out, and they're taking it to another level with their 2026 Coffee for the Troops campaign. This isn't just about a hot brew; it's about stirring up a storm of...

Continue Reading
Once Upon a Coconut Supports Breast Cancer Cause

Updated Category News Views 4

Supporting Breast Cancer Awareness When a coconut water brand shifts to pink, it's not just about changing colors—it's a signal of commitment. Every October, the world paints itself pink to stand against breast cancer, and Once Upon a Coconut is no different. This year, they're diving headfirst into Breast Cancer Awareness Month with their limited-edition pink cans, all...

Continue Reading
Beasley and Vegas Golden Knights Partner for Broadcast

Updated Category News Views 4

Strategic Moves on the Airwaves The Vegas Golden Knights are skating into a new era of broadcasting. Teaming up with Beasley Media Group, they've inked a multiyear deal that makes the media outfit their official audio partner. Dropping the puck on this relationship means folks in Southern Nevada can catch the action on Beasley's English and Spanish stations. It's a hefty...

Continue Reading
Colson Group Expands with Algood Acquisition

Updated Category News Views 11

A Big Move in Mobility Solutions Put on your seatbelts, because Colson Group is steering into a new lane with its acquisition of Algood Caster Innovations. This ain't just any pickup—it's a smart move that could ramp up their North American manufacturing clout and mobility solutions. You know, mergers like these don't come around by accident. Colson sees something...

Continue Reading
Class Action Lawsuit Hits Desert Resort Management

Updated Category News Views 4

Desert Resort Management in Labor Hot Seat Alright, here's a twist that might make your coffee spill—Desert Resort Management, Inc. is caught in a legal whirlwind in Riverside County. The heavy hitters at Blumenthal Nordrehaug Bhowmik De Blouw LLP have slapped a lawsuit right in their face, alleging some grimy labor practices. They're claiming that the company wasn't...

Continue Reading

Top 5 Most Recently Viewed Articles

ECARX Unveils Advanced AI Cockpit for Lynk & Co Vehicles

Updated Category News Views 201

ECARX Introduces Cutting-Edge AI Cockpit Technology ECARX Holdings Inc. (NASDAQ: ECX) recently announced the launch of its revolutionary Pikes computing platform alongside the enhanced Cloudpeak software stack. These advancements are set to transform the in-car experience for the new Lynk & Co 07 EM-P sedan and the 08 EM-P SUV. Powering the Future of Mobility The...

Continue Reading
VMware Securities Litigation Settlement Details Unveiled

Updated Category News Views 239

Overview of VMware Securities Litigation This article discusses the critical developments surrounding the VMware, Inc. securities litigation, where a settlement has been announced. This case is particularly significant for investors who purchased the company's stocks within a specified period. The announcement was made by Robbins Geller Rudman & Dowd LLP, a renowned law...

Continue Reading
Celebrate the Season with PetSmart's Festive Offerings

Updated Category News Views 222

Celebrating the Holidays with PetSmart's New Collection The holiday season is a joyous time for families, and PetSmart is making it even more special for pets and their parents. With the launch of the Merry & Bright collection, PetSmart offers a delightful array of festive apparel, accessories, treats, and toys. This collection aims to bring happiness to pets while...

Continue Reading
Amicus Therapeutics Engages Investors with November Presentations

Updated Category News Views 67

Amicus Therapeutics Engages Investors with November Presentations Amicus Therapeutics, a prominent entity in the biotechnology sector, has announced plans for key presentations at several investor conferences this November. This engagement promises to foster greater awareness of the company’s innovative approaches to treating rare diseases and seeking investment...

Continue Reading
S&P 500 Anticipates Major Gains Amid Tech Surge

Updated Category News Views 183

Exciting Times for the S&P 500 as Year-End Approaches As we look ahead in the financial landscape, the S&P 500 is set for a thrilling finale in 2024. With only a couple of months left in the year, it stands on the brink of achieving its largest annual gain this century. The upcoming weeks will be crucial; the performance in this period will likely dictate the S&P's...

Continue Reading